Regeneron Pharmaceuticals’ cocktail of two monoclonal antibodies was used to treat President Donald Trump for COVID-19. SEATTLE — Researchers at UW Medicine are partnering with the Fred Hutch Cancer Research Center to lead a study of Regeneron Pharmaceuticals’ antibody cocktail as a way to prevent COVID-19 infections. The researchers are […]
antibody
Stanford Medicine researchers are investigating whether a combination of specific antibodies can reduce early symptoms of COVID-19 in people with mild to moderate cases of the disease. Their effort is part of a multisite clinical trial of an antibody drug developed by Eli Lilly and AbCellera that aims to enroll […]
The University of Chicago Medicine is launching a clinical trial to examine the potential of an antibody against the SARS-CoV-2 spike protein for treating COVID-19, the disease caused by the novel coronavirus. For the BLAZE-1 trial, UChicago is recruiting 22 participants to be treated with the LY-CoV555 antibody developed by […]